Development of a Prognostic Scoring System for Hepatocellular Carcinoma Patients With Main Portal Vein Tumor Thrombus Undergoing Conventional Transarterial Chemoembolization: An Analysis of 173 Patients

BackgroundPatients with hepatocellular carcinoma (HCC) with main portal vein tumor thrombus (mPVTT) have poor prognosis. Promising systemic therapies, such as target therapies, have limited benefits. The purpose of this study is to retrospectively evaluate the benefits of conventional TACE (c-TACE)...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Jing-huan Li, Xin Yin, Wen-shuai Fan, Lan Zhang, Rong-xin Chen, Yi Chen, Li-xin Li, Ning-ling Ge, Yu-hong Gan, Yan-hong Wang, Zheng-gang Ren
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2021-08-01
Edice:	Frontiers in Oncology
Témata:	hepatocellular carcinoma (HCC) portal vein tumor thrombus (PVTT) transarterial chemoembolization (TACE) overall survival (OS) prognosis model
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fonc.2021.671171/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!